Inoxgen

Nitric Oxide, the active ingredient in Inoxgen, is a medical gas presented as a medical gas for endotracheopulmonary use. It treats neonatal pulmonary hypertension, acute respiratory distress syndrome, and persistent pulmonary hypertension of the newborn. GNH USA supplies Inoxgen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Inoxgen is used as a pulmonary vasodilator to manage conditions involving elevated pulmonary vascular resistance.

Neonatal pulmonary hypertension: improves oxygenation by reducing pulmonary arterial pressure. Acute respiratory distress syndrome: enhances gas exchange through selective pulmonary vasodilation. Persistent pulmonary hypertension of the newborn: lowers right‑ventricular afterload and supports systemic oxygen delivery.

Inoxgen may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Methemoglobinemia: elevated methemoglobin levels reducing oxygen transport. - Hypotension: systemic blood pressure reduction due to vasodilation. - Rebound pulmonary hypertension: rapid rise in pulmonary pressure after abrupt discontinuation. - Increased platelet aggregation: potential for clot formation.

Serious or Rare Side Effects: - Severe methemoglobinemia: may require urgent treatment. - Nitrogen dioxide toxicity: lung injury from NO2 formation. - Profound hypotension: can lead to organ hypoperfusion. - Pulmonary edema: fluid accumulation in lung tissue.

When using Inoxgen, careful monitoring and specific safety measures are essential. - Dose titration: adjust concentration based on continuous hemodynamic and oxygenation parameters. - Monitoring: continuously measure methemoglobin and nitrogen dioxide levels. - Contraindications: avoid in patients with severe left‑ventricular dysfunction. - Pregnancy: use only if potential benefits outweigh uncertain risks. - Interaction with other vasodilators: monitor for additive hypotensive effects. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area away from heat sources and protect from direct sunlight.

Inoxgen can interact with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Inhaled anesthetics (e.g., nitrous oxide): increased nitrogen dioxide formation. - Other nitric oxide donors: additive toxicity.

Moderate Interactions (Monitor Closely): - Systemic vasodilators (e.g., nitroglycerin): monitor blood pressure closely. - Bronchodilators: may enhance pulmonary vasodilation. - Anticoagulants: monitor for increased bleeding risk.